spacer
home > epc > Winter 2008
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in the current issue of EPC.
   
Text
PDF
bullet
Marketplace & Business
Trends in the CRO market over 2008 come under the microscope of Graham Hughes, Editor of EPC and a Pharmaceutical Consultant  
view
download pdf
Julianne Hull at Wyeth believes that with commitment and mutual respect, business process outsourcing can lead to benefits that are well worth the effort and initial outlay  
view
download pdf
Korea is one of the fastest growing countries for clinical trials. Young Jack Lee at LSK Global Pharma Services points out that, although holding trials in Korea may not be low-cost, it is certainly cost effective  
view
download pdf
bullet
Legal & Regulatory
Paul Ranson at Fasken Martineau LLP sets out guidelines for negotiating and drafting contracts for outsourcing clinical research  
view
download pdf
Edgar H Adams, Robert Bader and Robin Carter at Covance Periapproval Services investigate the recent history of and developments in risk aversion and clinical development  
view
download pdf
Kristiina Liljedahl and Linda Berggren at Borenius & Kemppinen discuss major changes in the Finnish pharmaceutical reimbursement system  
view
download pdf
bullet
Clinical Development
Russell Neal and Annamaria Muroni at Clinical Network Services urge companies to take a leap from the world they know and explore the opportunities that Australia has to offer  
view
download pdf
Lani Hashimoto and Kim Boericke at i3 Research discuss methods of streamlining clinical trials in order to save time and costs by improving efficiency  
view
download pdf
There is a silver lining to the economic crisis: the downturns have pushed companies into improving efficiency and productivity. Liz Moench at MediciGlobal provides 10 strategies for saving time and cost for patient recruitment and retention  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
Helen Brooker and Nicole Meinel at Cognitive Drug Research explain that assessing the cognitive effects of drugs at an early stage in clinical trials can reduce the likelihood of a drug failing at a later stage of development; thereby saving time and money  
view
download pdf
Rob Zuiker and Zuzana Diamant at Centre for Human Drug Research (CHDR) discuss the added value of non-invasive biomarkers in early phase clinical trials of asthma  
view
download pdf
Alan Goldberg at the Johns Hopkins University Center for Alternatives to Animal Testing and Thomas Hartung of the EU Joint Research Centre and the University of Konstanz believe that, although toxicology is in crisis, there is a silver lining: the situation represents a driving force for change, and offers enormous opportunities  
view
download pdf
bullet
Data Management & IT Solutions
Sam Singh at ACM-Pivotal explores the evolution of laboratory information management systems (LIMS) from the point of view of a global clinical trials organisation  
view
download pdf
Jules Mitchel and Irene Ghilezan at Target Health Inc, Theresa Luna and Susan Carroll at Prometheus Laboratories, and Aida Bibliowicz at Cato Research Ltd, feel that turning away from our love of paper is the best way to optimise clinical trials  
view
download pdf
Dave Kloc at Netezza explains how the pharmaceutical industry can satisfy its need for data analysis by identifying and employing data warehouse appliances  
view
download pdf
Patrick Baudouin at SDL examines why global regulations have been the catalyst for higher translation standards across the life sciences industry  
view
download pdf
With eCTD now being recommended by regulatory agencies in Europe and the US, Keith Williams at Good Products Ltd examines the problems and advantages this can offer, and evaluates the new technologies that are developing as a result  
view
download pdf
Gunter Bellaire, Kevin Jaynes and Bill Byrom at Perceptive Informatics evaluate different medical imaging systems to improve productivity and efficiency of clinical trials utilising core medical imaging components and eClinical integration points  
view
download pdf
bullet
LABS & Logistics
Peter Kralinger at Carrymed Pharma & Transport discusses how temperatures can be best maintained during periods of transportation through an integrated approach  
view
download pdf
Nigel Cryer at Hamdrake Services considers how logistics can complete a pharmaceutical dream or turn it into a nightmare  
view
download pdf
bullet
ECG CORE LABS & CARDIAC SAFETY
Recent findings demonstrating serious safety issues with certain anti-diabetic drugs have led to increased guidelines and legislation. Didier Saur at ICON Clinical Research examines this and argues that reducing cardiovascular risk must always be the primary concern  
view
download pdf
Pascal Voiriot at CardiaBase examines a recent roundtable discussion on the guidelines surrounding cardiac safety and looks ahead to the future  
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Merck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound


More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement